用32P后标记分析法研究抗肿瘤1-硝基-9-氨基吖啶与HeLa S3细胞DNA形成的DNA加合物 - Suppr | 超能文献

32P-post-labelling analysis of DNA adducts formed by antitumor 1-nitro-9-aminoacridines with DNA of HeLa S3 cells.

作者信息

Bartoszek A, Konopa J

机构信息

Department of Pharmaceutical Technology and Biochemistry, Technical University of Gdańsk, Poland.

出版信息

Biochem Pharmacol. 1987 Dec 1;36(23):4169-71. doi: 10.1016/0006-2952(87)90577-6.

DOI:10.1016/0006-2952(87)90577-6

Abstract

摘要

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

文档翻译

学术文献翻译模型，支持多种主流文档格式。

相似文献

1

32P-post-labelling analysis of DNA adducts formed by antitumor 1-nitro-9-aminoacridines with DNA of HeLa S3 cells.用32P后标记分析法研究抗肿瘤1-硝基-9-氨基吖啶与HeLa S3细胞DNA形成的DNA加合物

Biochem Pharmacol. 1987 Dec 1;36(23):4169-71. doi: 10.1016/0006-2952(87)90577-6.

2

32P-post-labeling analysis of DNA adduct formation by antitumor drug nitracrine (Ledakrin) and other nitroacridines in different biological systems.用32P后标记分析法研究抗肿瘤药物硝吖啶（雷得菌素）及其他硝基吖啶在不同生物系统中形成DNA加合物的情况。

Biochem Pharmacol. 1989 Apr 15;38(8):1301-12. doi: 10.1016/0006-2952(89)90337-7.

3

DNA damage in HeLa s3 cells by an antitumor drug Ledakrin and other antitumor 1-nitro-9-aminoacridines.一种抗肿瘤药物莱达克林及其他抗肿瘤1-硝基-9-氨基吖啶对HeLa s3细胞的DNA损伤

Chem Biol Interact. 1984 May;49(3):311-28. doi: 10.1016/0009-2797(84)90105-4.

4

32P-post-labelling analysis of nucleobases involved in the formation of DNA adducts by antitumor 1-nitroacridines.通过抗肿瘤1-硝基吖啶形成DNA加合物所涉及的核碱基的32P后标记分析

Chem Biol Interact. 1997 Feb 28;103(2):131-9. doi: 10.1016/s0009-2797(96)03753-2.

5

The mode of action of cytotoxic and antitumor 1-nitroacridines. II. In vivo enzyme-mediated covalent binding of a 1-nitroacridine derivative, Ledakrin or Nitracrine, with dna and other macromolecules of mammalian or bacterial cells.细胞毒性和抗肿瘤1-硝基吖啶的作用模式。II. 1-硝基吖啶衍生物（雷达克林或硝吖啶）在体内通过酶介导与哺乳动物或细菌细胞的DNA及其他大分子的共价结合

Chem Biol Interact. 1983 Feb;43(2):151-73. doi: 10.1016/0009-2797(83)90093-5.

6

Interaction of 9-aminoacridine, ethidium bromide and harman with DNA characterized by size exclusion high-performance liquid chromatography.

J Chromatogr. 1983 Dec 23;281:348-54. doi: 10.1016/s0021-9673(01)87898-5.

7

Hypoxia-selective antitumor agents. 1. Relationships between structure, redox properties and hypoxia-selective cytotoxicity for 4-substituted derivatives of nitracrine.缺氧选择性抗肿瘤剂。1. 硝吖啶4-取代衍生物的结构、氧化还原性质与缺氧选择性细胞毒性之间的关系。

J Med Chem. 1989 Jan;32(1):23-30. doi: 10.1021/jm00121a006.

8

[Biotransformation of 9-(p-methylanilino) acridine in the rabbit].[9-(对甲基苯胺基)吖啶在兔体内的生物转化]

Zhongguo Yao Li Xue Bao. 1983 Mar;4(1):63-7.

9

DNA intercalating properties of tetrahydro-9-aminoacridines. Synthesis and 23Na NMR spin-lattice relaxation time measurements.四氢-9-氨基吖啶的DNA嵌入特性。合成及23Na核磁共振自旋晶格弛豫时间测量。

J Med Chem. 1990 Jan;33(1):93-7. doi: 10.1021/jm00163a015.

10

The mechanism of inhibition of DNA replication in HeLa S3 cells by the antitumor drug Ledakrin and other antitumor 1-nitro-9-aminoacridines.抗肿瘤药物莱达克林及其他抗肿瘤1-硝基-9-氨基吖啶对HeLa S3细胞DNA复制的抑制机制

Biochim Biophys Acta. 1985 Jun 24;825(2):244-53. doi: 10.1016/0167-4781(85)90109-5.

引用本文的文献

1

Absorption and luminescence spectroscopic analysis of tautomeric forms of protonatedN,N-dimethyl-N'-(1-nitro-9-acridinyl)-1,3-propanediamine (nitracrine) and its nitro isomers in poly(vinyl alcohol) films.质子化 N,N-二甲基-N'-(1-硝基-9-吖啶基)-1,3-丙二胺（硝卡嗪）及其硝基异构体在聚乙烯醇薄膜中的互变异构形式的吸收和荧光光谱分析。

J Fluoresc. 1991 Mar;1(1):57-68. doi: 10.1007/BF00865259.